header-4.jpg
About Us

Farhana Matin

Farhana Matin

Positions

  • PhD Candidate, APCRC-Q, Queensland University of Technology

Contact Details

Phone
+61 7 3443 7250
Linkedin profile
https://www.linkedin.com/in/farhana-matin-64202979/

Qualifications

  • PhD Candidate School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Australia, 2014-present
  • Bachelor of Science in Biochemistry and Biotechnology, North South University, Dhaka, Bangladesh, 2012

Biography

Farhana Matin is a current PhD candidate in A/Prof Batra's group at the Queensland University of Technology (QUT) after successful articulation from Masters in Applied Science in 2015. Her current project focuses on microRNA based biomarkers and therapy for prostate cancer. She has expertise in cell culture, nucleic acid extractions from plasma, real time PCR, miRNA functional assays, data analysis, statistical analysis, animal handling, in vivo experiments/ imaging, etc. She has participated in more than 20 scientific conferences/ competitions during her candidature and was awarded many times based on her performance. She has previously trained a BSc student on placement and worked with High school students as part of the STEM Program. She has also been an active member of the IHBI Inspires Postgraduate Student Conference organising committee and holds other professional memberships at present. Farhana completed a BSc in Biochemistry and Biotechnology from North South University, Dhaka, Bangladesh. Due to her excellent academic record she was selected to work as an Elective Fellow at the International Centre for Diarrheal Diseases Research, Bangladesh (ICDDR, B).

She is part of a team working towards development of microRNA-based diagnostics and therapeutics for the accurate detection and treatment of prostate cancer (PCa). PCa is a major cause of cancer-related deaths in men worldwide and the most commonly diagnosed cancer in Australian men with an estimated number of 16,665 new cases diagnosed and 3,452 deaths in 2017 according to the Prostate Cancer Foundation of Australia (PCFA). There has been an ongoing issue relating to the diagnostic accuracy and harmful side effects of currently available biomarkers for e.g. Prostate specific antigen (PSA) and therapeutics for e.g. chemotherapy, radiation or hormone therapy. They anticipate that their approach to have improved accuracy and fewer side effects in comparison to the currently available cancer detection and treatment options, as they intend to harness the mechanism of fine-tuning of the genome through microRNA detection and replacement. This may potentially improve prostate cancer management and survival outcome in PCa patients.

Awards and grants

Awards

Year

Title

2017

Australasian Genomics Technologies Association (AGTA) Travel Award

2017

Judges’ Choice Runner Up (Poster), IHBI Inspires Postgraduate Student Conference 

2017

1st Runner Up (Faculty Level), Three Minute Thesis (3MT) Competition

2016

Judges’ Choice Runner Up (Oral), IHBI Inspires Postgraduate Student Conference

2016

Judges’ Choice Runner Up (Poster- Science to Business Category), TRI Symposium

2016

Falling Walls Lab Australia Travel Award (Selected as Top 25)

2016

2nd Runner Up (Faculty Level), Three Minute Thesis (3MT) Competition

2016  

Winner (School Level), Three Minute Thesis (3MT) Competition

2015

Judges’ Choice 3rd Prize (Oral), TRI Symposium

Research interests

microRNA, gene-regulation, biomarkers, therapeutics, theranostics, precision medicine, prostate cancer

Current research projects

  • The diagnostic and prognostic potential of minimally invasive plasma microRNA biomarkers for the detection of aggressive prostate cancer
  • miR-3162-5p mediates prostate cancer progression by targeting the prostate specific antigen (PSA) and other members of the kallikrein family
  • Exploring the therapeutic potential of microRNAs for prostate cancer treatment  

Top publications

  • Matin F, Jeet V, Clements JA, Yousef GM, Batra J. MicroRNA Theranostics in Prostate Cancer Precision Medicine. Clinical Chemistry. 2016; 62(10):1318-33. doi: 10.21037/tcr.2017.01.21
  • Matin F, Batra J. A MicroRNA Molecular Signature of Aggressive Prostate Cancer (Commentary). Translational Cancer Research. 2017. doi: 10.21037/tcr.2017.01.21
  • Matin F, Jeet V, Moya L, Selth LA, Chambers S, Australian Prostate Cancer BioResource, Clements JA, Batra J. A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer. Scientific Reports. 2017. (Under revision)
More publications are available on PubMed

Professional memberships and associations

Year

Title, Organisation

2017

Member, Australasian Genomic Technologies Association (AGTA)

2017

Mentee, Industry Mentoring Network in STEM (IMNIS) Program

2017

Member, Women in Technology (WiT)

2016  

Member, Australia and New Zealand Society for Cell and Developmental  Biology (ANZSCDB)

2016

Member, IHBI Inspires Postgraduate Student Committee 

2016

Member, The Australian Society for Medical Research (ASMR)